{"entity":{"type":"insider","cik":"0001727334","url":"/insider/0001727334","json_url":"/insider/0001727334.json","name":"Robinson Chandler","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2019-12-20","last":"2025-09-26","span_basis":"filed_date"},"name_variants":[{"name":"Robinson Chandler","source":"filing","n_filings":5,"first_seen":"2019-12-20","last_seen":"2025-09-26"}],"transactions":[{"id":5166761,"accession":"0001437749-25-029925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-029925","line_url":"/filing/0001437749-25-029925#line-1","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC; Brown Michael J; Mazar Andrew Paul","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550229.0,"shares_display":"550,229","price_per_share":63.6098,"price_display":"63.61","price_state":"stated","total_value":34999956.6442,"total_display":"34,999,956.64","shares_owned_after":272026.0,"shares_owned_after_display":"272,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-26","scope":"insider"},{"id":4814098,"accession":"0001437749-25-022861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-022861","line_url":"/filing/0001437749-25-022861#line-1","is_derivative":false,"issuer_cik":"0001645469","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001645469","owner_cik":"0001727334","owner_name":"Robinson Chandler","owner_url":"/insider/0001727334","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16800.0,"shares_display":"16,800","price_per_share":40.0012,"price_display":"40.00","price_state":"stated","total_value":672020.16,"total_display":"672,020.16","shares_owned_after":73472.0,"shares_owned_after_display":"73,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-16","scope":"insider"},{"id":4921283,"accession":"0001437749-25-011068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-011068","line_url":"/filing/0001437749-25-011068#line-1","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"O'Halloran Thomas V.; Mazar Andrew Paul; Robinson Chandler; Tactic Pharma LLC; Brown Michael J","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33334.0,"shares_display":"33,334","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":1166690.0,"total_display":"1,166,690.00","shares_owned_after":822255.0,"shares_owned_after_display":"822,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-04","scope":"insider"},{"id":4739815,"accession":"0001654954-21-001750","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001654954-21-001750","line_url":"/filing/0001654954-21-001750#line-5","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42467.0,"shares_display":"42,467","price_per_share":13.3,"price_display":"13.30","price_state":"stated","total_value":564811.1,"total_display":"564,811.10","shares_owned_after":249200.0,"shares_owned_after_display":"249,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":4739812,"accession":"0001654954-21-001750","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001654954-21-001750","line_url":"/filing/0001654954-21-001750#line-4","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29996.0,"shares_display":"29,996","price_per_share":15.12,"price_display":"15.12","price_state":"stated","total_value":453539.52,"total_display":"453,539.52","shares_owned_after":194980.0,"shares_owned_after_display":"194,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":4739808,"accession":"0001654954-21-001750","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001654954-21-001750","line_url":"/filing/0001654954-21-001750#line-3","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24224.0,"shares_display":"24,224","price_per_share":14.09,"price_display":"14.09","price_state":"stated","total_value":341316.16,"total_display":"341,316.16","shares_owned_after":224976.0,"shares_owned_after_display":"224,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":4739805,"accession":"0001654954-21-001750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-21-001750","line_url":"/filing/0001654954-21-001750#line-2","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16384.0,"shares_display":"16,384","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":269352.96,"total_display":"269,352.96","shares_owned_after":178596.0,"shares_owned_after_display":"178,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":4739800,"accession":"0001654954-21-001750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-21-001750","line_url":"/filing/0001654954-21-001750#line-1","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11929.0,"shares_display":"11,929","price_per_share":16.9,"price_display":"16.90","price_state":"stated","total_value":201600.1,"total_display":"201,600.10","shares_owned_after":166667.0,"shares_owned_after_display":"166,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":8331716,"accession":"0001654954-19-014150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-19-014150","line_url":"/filing/0001654954-19-014150#line-1","is_derivative":false,"issuer_cik":"0001035909","issuer_name":"Monopar Therapeutics","issuer_ticker":"MNPR","issuer_name_source":null,"issuer_url":"/issuer/0001035909","owner_cik":null,"owner_name":"Brown Michael J; Mazar Andrew Paul; O'Halloran Thomas V.; Robinson Chandler; Tactic Pharma LLC","owner_url":null,"role":"Director, Officer (Chief Executive Officer; Chief Scientific Officer), Ten percent owner","officer_title":"Chief Executive Officer; Chief Scientific Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":291667.0,"shares_owned_after_display":"291,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645469","name":"Monopar Therapeutics","url":"/issuer/0001645469","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":5,"first_seen":"2019-12-20","last_seen":"2025-09-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727334","retrieved_at":"2026-08-21T03:37:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}